Database

Startups

Main Industry
Health Care
Main Product/Service
"Autologous Dendritic Cell/ Tumor Antigen" ADCTA cancer immunotherapy
Founded Year
2011
Unified Business No.
53527046
Status
Active
Number of Employees
17
Total Paid-in Capital
699,860,000 (NT$)
Location of Company
Taiwan , Hsinchu County
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Introduction
SSC, Safe Save Medical Cell Sciences & Technology CO., Ltd was founded in 2011, engaged in the development of cancer immunotherapy, owns the technology of autologous Dendritic Cells/Tumor Antigens (ADCTA) immunotherapy, and develops autologous immune tail



More2 ↓

Similar Companies

HONYA MEDICAL CO., LTD.

1. Cell Therapy
2. Clinical trial
3. MCRcI®
4. MiSaver®

TAIWAN BIO THERAPEUTICS INC.

Leveraging the FAST CGT platform to enhance the specificity, persistence, and stability of regulatory T cells, improving their ability to restore immune tolerance and suppress inflammation as a targeted alternative to non-selective, high-risk immunosuppre

UWELL BIOPHARMA INC.

Our therapy involves genetically modifying a patient’s T cells outside the patient’s body, transforming the T cells to express chimeric antigen receptors (CARs), and then reinfusing the engineered T cells back into the patient.
:::